Company intelligence / Profile preview

High Park Company

London, Ontario, Canada

Ownership: Private
Employees: ~125
Development stage: Other

Overview

The company manufactures, packages, and distributes a portfolio of adult-use cannabis brands. Tilray, its parent, continues to supply pharmaceutical-grade medical cannabis in Canada and globally. High Park has facilities for flower, pre-rolls, extracts, edibles, and beverages but does not run drug trials.

Therapeutic areas: OtherPsychiatry
Modalities: Small moleculePlant-derived product
Industry: Food & Nutrition

Partnerships

Canadian provincial supply agreements (Quebec, Manitoba, others)Internal operational partnership with Tilray for cultivation, Canadian distribution

Beyond the preview

Go deeper on High Park Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on High Park Company.

Explore the full profile